Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Peter A. Ryg"'
Autor:
Patrick Y. Wen, Brian J. Scott, Tracy T. Batchelor, Margaret B. McNamara, Peter A. Ryg, Eudocia C. Quant
Publikováno v:
Neuro-Oncology. 12:603-607
Agents targeting the vascular endothelial growth factor (VEGF) pathway are being used with increasing frequency in patients with recurrent high-grade glioma. The effect of more than one antiangiogenic therapy given in succession has not been establis
Autor:
Percy Ivy, Emmanuelle di Tomaso, Tracy T. Batchelor, A. Gregory Sorensen, Elizabeth R. Gerstner, Rakesh K. Jain, Peter A. Ryg, Jay S. Loeffler, Dan G. Duda
Publikováno v:
Nature Reviews Clinical Oncology. 6:229-236
Most brain tumors oversecrete vascular endothelial growth factor (VEGF), which leads to an abnormally permeable tumor vasculature. This hyperpermeability allows fluid to leak from the intravascular space into the brain parenchyma, which causes vasoge
Autor:
Rebecca A. Betensky, Michael Silver, Catherine L. Nutt, David N. Louis, K. McCormack, Eudocia C. Quant, Peter A. Ryg, K. Provencher, Stephen Yip, Tracy T. Batchelor
Publikováno v:
Journal of Clinical Oncology. 27:e13021-e13021
e13021 Background: Survival of patients with glioblastoma (GBM) remains poor. However, a small percentage of GBM patients live ≥ 3 years. Relatively little is known about the patterns of care and outcomes of these long term survivors relative to GB
Autor:
Scott, Brian J., Quant, Eudocia C., McNamara, Margaret B., Ryg, Peter A., Batchelor, Tracy T., Wen, Patrick Y.
Publikováno v:
Neuro-Oncology; Jun2010, Vol. 12 Issue 6, p603-607, 5p, 3 Charts